Researchers from the University of Oxford have developed a groundbreaking tool based on data from over 5.6 million people, demonstrating that 98% of candidates for statin treatment face a low risk of serious complications. Published in The Lancet Digital Health, this study aims to alleviate fears that often lead patients to interrupt essential treatment for preventing heart attacks and strokes.
Recent research supports the use of these widely prescribed medications for lowering cholesterol and protecting cardiovascular health. Muscle-related side effects, the primary concern for patients taking statins, have been found to be significantly less frequent than previously believed. This brings reassurance to millions of people worldwide who rely on this treatment.
Un estudio confirmó que los tratamientos médicos para adelgazar, incluidos algunos medicamentos GLP-1, pueden causar caída del cabello como efecto secundario poco conocido. Es una pérdida temporaria que se revierte al suspender el fármaco, según los expertos.
Alfredo S. Quiroga
